February 13, 2007

A new kind of business model is evolving in the pharmaceutical world: sprouted out of too much data.

Difficult to imagine such a thing. Knowledge is power, 'tis said; and thus raw knowledge must necessarily be a desirable thing: more computer memory, more education, more information streams, more facts -- and yet facts in and of themselves mean nothing. With the completion of the outline sketch of the Human Research Project, too much is suggested even for a single source in isolation to identify all the appropriate questions, let alone pursue all potential lines of research.

Thus, open up the raw data. Make it public without cost to a globe of university and private researchers, let loose the million monkeys to slave upon the million typewriters ... and monitor the results closely, always prepared to snatch away what gleamings of coherence might coelesce.

Comments: Post a Comment

<< Home